GLP-1 Agents Showed Broader Risks, Rewards in 2025

By News Health
3 days Ago

(MedPage Today) — In January 2025, we reported about an observational study of nearly 2 million U.S. military veterans that showed a broad spectrum of possible risks and benefits associated with GLP-1 receptor agonists. In this report, we follow…

Source link : https://www.medpagetoday.com/endocrinology/obesity/119252

Author :

Publish date : 2026-01-03 15:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

First Transcatheter Coronary Bypass; Y Chromosome Loss & MI; GLP-1s vs Brain Bleeds

NHS England Names First Services for Online Hospital

The first quantum fluctuations set into motion a huge cosmic mystery

GLP-1 Drug Market Changes; Wegovy Pill Hits Shelves; Hypercortisolism Drug Rejected

Blinatumomab Consolidation Well Tolerated in MRD-Negative ALL

Passwords will be on the way out in 2026 as passkeys take over